Abstract
A library of epitope-defined antiganglioside monoclonal antibodies has been used to analyze the ganglioside phenotype of human glioma cell lines, rodent xenografts derived from them, and a separate panel of human glioma biopsies by multiple quantitative and qualitative assays. We have shown that the ganglioside phenotypes of cultured cell lines differ from the ganglioside phenotypes in the xenografts grown from the parent lines. The lacto series gangliosides 3′-isoLM1 and 3′, 6′-isoLD1 are expressed in the majority of primary human central nervous system neoplasms and xenografts derived from glioma cell lines, whereas glioma cell lines themselves express 3′-isoLM1 and 3′, 6′-isoLD1 in only 2/15 and 0/15 cases, respectively. Examination of the ganglioside profiles of serially passaged xenografts established from the glioma cell line D-54 MG, which does not express the lacto series, revealed the appearance of these gangliosides within one to two passages in vivo. The presence of these defined gangliosides in the majority of human gliomas and their absence in normal brain supports their application in compartmental therapy of primary central nervous sytem tumors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fredman P., von Holst H., Collins V. P., Granholm L., and Svennerholm L. (1988) Sialyllactotetraosylceramide, a ganglioside marker for human malignant gliomas.J. Neurochem. 50, 912–919.
Fredman P., Månsson, J.-E., Bigner S. H., Wikstrand C. J., Bigner D. D., and Svennerholm L. (1990) Gangliosides in the human glioma cell line U-118 MG grown in culture or as xenografts in nude rats.Biochim. Biophys. Acta 1045, 239–244.
Fredman P., von Holst H., Collins V. P., Dellheden B., and Svennerholm L. (1993) Expression of gangliosides GD3 and 3′-isoLM1 in autopsy brains from patients with malignant tumors.J. Neurochem. 60, 99–105.
Gottfries J., Fredman P., Månsson J.-E., Collins V. P., von Holst H., Armstrong D. D., Percy A. K., Wikstrand C. J., Bigner D. D., and Svennerholm L. (1990) Determination of gangliosides in six human primary medulloblastomas.J. Neurochem. 55, 1322–1326.
He X., Wikstrand C. J., Fredman P., Månsson J.-E., Svennerholm L., and Bigner D. D. (1989) GD3 expression by cultured cells of neuroectodermal origin.Acta Neuropathol. 79, 317–325.
Longee D. C., Wikstrand C. J., Månsson J.-E., He X., Fuller G. N., Bigner S. H., Fredman P., Svennerholm L., and Bigner D. D. (1991) Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.Acta Neuropathol. 82, 45–54.
Månsson J.-E., Fredman P., Bigner D. D., Molin K., Rosengren B., Friedman H. S., and Svennerholm L. (1986) Characterization of new gangliosides of the lactotetraose series in murine xenografts of a human glioma cell line.FEBS Lett. 201, 109–113.
Sambrook J., Fritsch E. G., and Maniatis T. (1989) Enzymes used in molecular cloning, inMolecular Cloning. A Laboratory Manual (Sambrook J., Fritsch E. G., and Maniatis T., eds.), 2nd ed., pp. 5.2–5.95, Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
Svennerholm L., Fredman P., Jungbjer B., Månsson J.-E., Haberg B., Noren L., and Santavouri P. (1987) Large alteration in the ganglioside and neutral glycolipid patterns in INCL/PFAL brains.J. Neurochem. 49, 1772–1783.
Tsuchida T., Ravindranath M. H., Saxton R. E., and Irie R. F. (1987) Gangliosides of human melanoma: altered expression in vivo and in vitro.Cancer Res. 47, 1278–1281.
Vrionis F. D., Wikstrand C. J., Fredman P., Månsson J.-E., Svennerholm L., Bigner D. D. (1989) Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.Cancer Res. 49, 6645–6651.
Wikstrand C. J., He X., Fuller G. N., Bigner S. H., Fredman P., Svennerholm L., and Bigner D. D. (1991) Occurrence of lacto series gangliosides 3′-isoLM1 and 3′, 6′-isoLD1 in human gliomas in vitro and in vivo.J. Neuropathol. Exp. Neurol. 50, 756–769.
Wikstrand C. J., Longee D. C., McLendon R. E., Fuller G. N., Friedman H. S., Fredman P., Svennerholm L., and Bigner D. D. (1993) Lactotetraose series ganglioside 3′, 6′-isoLD1 in tumors of central nervous and other systems in vitro and in vivo.Cancer Res. 53, 120–126.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wikstrand, C.J., Fredman, P., McLendon, R.R. et al. Altered expression of ganglioside phenotypes of human gliomas in vivo and in vitro. Molecular and Chemical Neuropathology 21, 129–138 (1994). https://doi.org/10.1007/BF02815347
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02815347